BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21736475)

  • 1. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
    Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
    Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
    Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999].
    Berger C; Trombert-Paviot B; Mitton N; Frappaz D; Galambrun C; Plantaz D; Dupuis S; Bertrand Y; Philippe N; Schell M; Marec-Bérard P; Bergeron C; Armari-Alla C; Pagnier A; Stephan JL; Freycon F
    Arch Pediatr; 2006 Feb; 13(2):121-9. PubMed ID: 16376530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
    Lacour B; Desandes E; Mallol N; Sommelet D
    Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long term mortality of five-year survivors of childhood cancer in Rhône-Alpes region].
    Trombert-Paviot B; Frappaz D; Casagranda L; Plantaz D; Bertrand Y; Stephan JL; Berger C; Freycon F
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):383-90. PubMed ID: 19013040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.
    Devarahally SR; Severson RK; Chuba P; Thomas R; Bhambhani K; Hamre MR
    Pediatr Hematol Oncol; 2003 Dec; 20(8):617-25. PubMed ID: 14578032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhône-Alpes region in France (ARCERRA).
    Freycon F; Trombert-Paviot B; Casagranda L; Bertrand Y; Plantaz D; Marec-Bérard P
    Pediatr Blood Cancer; 2008 Jun; 50(6):1213-20. PubMed ID: 18300318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
    Inskip PD
    Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
    Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.